GlobeNewswire by notified

AscendEX Appoints Shane Molidor as New CEO

Share

Singapore, June 09, 2022 (GLOBE NEWSWIRE) -- AscendEX, a global cryptocurrency financial platform, announced today that Shane Molidor has been appointed Chief Executive Officer. He succeeds the exchange’s founding partner, George Cao, who will continue to support AscendEX as Chairman.

Shane Molidor joined AscendEX (Formerly BitMax) in May of 2019 as Head of Business Development and was promoted to Chief Revenue Officer (CRO) in December of 2021. Molidor has worked professionally in the cryptocurrency industry since 2015 at top-tier institutions in both the United States and China.

 A highly-regarded leader, Molidor brings to the role an intimate understanding of exchange infrastructure, custody solutions, evolving regulations, and marketplace dynamics spanning both Eastern and Western Demographics.

 “I am confident to pass AscendEX’s reins to Shane”, Says George Cao, Former Ceo and Co-Founder, “I want to thank my team and community over the past five years for the endearing support you’ve had in me and this company, and for the confidence entrusted to my exceedingly qualified successor.

I will remain involved and continue to support AscendEX’s Board of Directors as Chairman.

Shane Molidor is the right choice to fill this role as he has helped manage and shape this company, holds a deep understanding of the complexities of this market and brings an unmatched commitment to the position. This decision is made with a great deal of trust and optimism for the future of this brand. ”

Molidor began his career in Strategy Consultation at the International Business Machines Corporation (IBM) after receiving his Bachelor’s Degree from Princeton University. He then worked at Gemini, a cryptocurrency exchange and custodian, in Business Development, Institutional Sales, and Client Services. Most recently, Molidor was the Global Head of FBG One at FBG Capital, a diversified financial institution dedicated to the cryptocurrency and blockchain sectors.

Following a $50mm Series B fundraise for AscendEX in November of 2021, Molidor shares his excitement regarding the company’s expansion. Since joining AscendEX, Molidor has grown the team from 15 to 65, coaching each employee to be a subject matter expert in their respective field, as well as encouraging a keen understanding of market microstructure and the ever-evolving cryptocurrency ecosystem. Molidor shares his excitement about revamping the platform’s user experience, the addition of new, comprehensive products, and the future state of the company.

“I am honored to have the opportunity to succeed George and lead AscendEX into a new phase of progress and growth,” notes Molidor. “As we continue to build, I am confident in the vision and the road ahead for this company, this team, and AscendEX users.”

AscendEX is making crypto trading easier with innovative new products and an enhanced user experience. Follow our journey at www.AscendEX.com.

About AscendEX

AscendEX is a global cryptocurrency financial platform with a comprehensive product suite including spot, margin, and futures trading, wallet services, and staking support for over 200 blockchain projects such as bitcoin, ether, and ripple. Launched in 2018, AscendEX services over 1 million retail and institutional clients globally with a highly liquid trading platform and secure custody solutions.

AscendEX has emerged as a leading platform by ROI on its “initial exchange offerings” by supporting some of the industry’s most innovative projects from the DeFi ecosystem such as Thorchain, xDai Stake, and Serum. AscendEX users receive exclusive access to token airdrops and the ability to purchase tokens at the earliest possible stage.

For more information and updates, please visit:

Website: https://ascendex.com

Twitter: https://twitter.com/_ascendex

Telegram: https://t.me/AscendEXEnglish

Medium: https://medium.com/ascendex

Instagram: https://instagram.com/_ascendex/

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 202224.6.2022 22:05:00 CEST | Press release

REPORT –ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Cambridge, MA (U.S.) and Lyon (France), June24, 2022 – ERYTECH Pharma (Nasdaq& Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announcedthat its Annual General Meeting was held on Friday, June 24, 2022. At the meeting, all resolutions for which the Board of Directors recommended a vote in favor were adopted, including: Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2021;Allocation of the financial year's results;Approval of the statutory auditors’ special report on regulated agreements and commitments with related parties;Approval of the elements of total compensation and benefits paid or allocated for the year ended December 31, 2021, to Gil BEYEN, Chief Executive Officer and Jean-Paul KRESS, Chairman of the Board;Approval of the compens

Cleantech Building Materials: Results of Annual General Meeting24.6.2022 14:54:27 CEST | Press release

24 June 2022 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER: CBM ISIN: GBOOBD1LVD21 CLEANTECH BUILDING MATERIALS PLC Results of Annual General Meeting The Annual General Meeting (“AGM”) of Cleantech Building Materials plc (“CBM” or the “Company”) was held in London earlier today, 24 June 2022. Details of the resolutions to be considered at the AGM were published in the Notice of AGM which was posted to Shareholders on 1 June 2022 and is available on the Company’s website: www.cbm-plc.com. All resolutions as set out in the Notice of AGM were duly passed without discussion. In particular, the following resolutions were passed at the AGM. The AGM resolved to authorise the directors of the Company to allot shares and grant rights to subscribe for, or convert any security, into shares. The directors of the Company sought authority for the purposes of section 551 of the Companies Act to exercise all the powers of the Company to allot shares and grant ri

Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia24.6.2022 13:13:19 CEST | Press release

With unique STAMP mechanism of action, Scemblix could provide a new option for patients in Europe with chronic myeloid leukemia (CML) who have suffered intolerance or inadequate response with at least two prior tyrosine kinase inhibitor treatments1 Positive opinion based on data from pivotal Phase III ASCEMBL trial, showing a near doubling in major molecular response rate for patients treated with Scemblix® (asciminib) vs. Bosulif®* (bosutinib) (25.5% vs. 13.2%) and more than three times lower discontinuation rate due to adverse reactions (5.8% vs 21.1%) at 24 weeks1 CHMP recommendation comes after the approval of Scemblix by the US FDA and other countries’ regulatory authorities, potentially broadening access for more patients to Novartis transformative therapies in CML Basel, June 24, 2022 — Novartis today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing au

Clariant’s shareholders approve all agenda items24.6.2022 11:30:00 CEST | Press release

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Integrated Report and Group Consolidated Financial Statements for fiscal year 2021 approvedGünter von Au reelected as Chairman of the Board of DirectorsThree new candidates join the Board of Directors: Ahmed Mohamed Alumar, Roberto César Gualdoni, Naveena ShastriConfirmed distribution of CHF 0.40 per shareKPMG confirmed as statutory auditor from 2022 MUTTENZ, JUNE 24, 2022 Clariant, a focused, sustainable, and innovative specialty chemical company, today held its 27th Annual General Meeting (AGM) where the shareholders approved all agenda items and resolutions as proposed by the Board of Directors. The AGM was held virtually, where shareholders were able to exercise their rights exclusively via the independent proxy. Overall, 698'945'298 shares or around 70.19 % of the share capital of Clariant were represented. Günter von Au was reelected as Chairman of the Board of Directors. Additionally, three new members were voted to join by a large majo

Cool Company Ltd. – Mandatory Notification Of Trade24.6.2022 11:01:19 CEST | Press release

EPS Ventures Ltd., close associate of Cyril Ducau, Chair of the Board of Cool Company Ltd. (the “Company”), has on 23 June 2022 acquired 7,865 shares in the Company at a price of NOK 90.274882 per share. Following the transaction, EPS Ventures Ltd. holds a total of 15,591,218 shares in the Company, equivalent to 38.97% of the Company’s shares. Please see the attached notification form in accordance with the Market Abuse Regulation article 19. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Primary insider notification form